Norges Bank Eq Rx, Inc. Transaction History

Norges Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2024	BUY	$1.66 - $2.31 $5.69 Million - $7.92 Million	3,427,100 New	3,427,100 $7.61 Million
Q2 2023 Aug 14, 2024	BUY	$1.61 - $1.96 $5.52 Million - $6.72 Million	3,427,100 New	3,427,100 $6.37 Million
Q1 2023 May 15, 2024	BUY	$1.8 - $2.83 $7.15 Million - $11.2 Million	3,969,700 New	3,969,700 $7.7 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.